← Leaderboards
Daniel Thomas Claiborne
Wistar Institute
$5,097,444
Attributed
$5,097,444
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,097,444 · 5
By mechanism
R01$4,130,589 · 2
R21$498,645 · 1
K22$270,000 · 1
F32$198,210 · 1
Top collaborators
No co-investigators on record.
Most similar at Wistar Institute
Same institution · by research overlap
- Mohamed Abdel Mohsen$12,661,177
Others in their field
Other Emerging Leaders on “Mouse Model”
- James Dale Berry · Brigham And Women'S Hospital$25,017,559
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$13,186,126
- Nuno Macarico Da Costa · Allen Institute$11,726,937
- Forrest Christie Collman · Allen Institute$11,726,937
- Jacqueline K White · Jackson Laboratory$11,670,339
- Thomas Dick · Rbhs-New Jersey Medical School$11,611,284
Research focus
Mouse ModelReceptorChronicImmune ResponseCellsPhenotypeAcutePathway InteractionsInfectionMorbidity - Disease RateHiv InfectionsIn VivoViralViral Load ResultMortalityHumanized MouseCd4 Positive T LymphocytesTissuesT-LymphocyteMapsMolecularAllelesIncidenceNew Therapeutic Target
Grant awards (14)
Role of the p53 P47S mutation in influencing prevalence and immune response to H. pylori$600,349
R01 · FY2025 · DK · contact PI
Developing potent HIV-specific CAR T cells through optimizing antigen sensitivity$558,595
R01 · FY2025 · AI · contact PI
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans$576,336
R01 · FY2024 · DK · contact PI
Developing potent HIV-specific CAR T cells through optimizing antigen sensitivity$558,595
R01 · FY2024 · AI · contact PI
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans$600,349
R01 · FY2023 · DK · contact PI
Engineering HIV-resistant CAR T cells for a functional HIV cure$225,195
R21 · FY2023 · AI · contact PI
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans$600,349
R01 · FY2022 · DK · contact PI
Engineering HIV-resistant CAR T cells for a functional HIV cure$273,450
R21 · FY2022 · AI · contact PI
Overcoming the hurdles to successful CAR T cell therapy for a functional HIV cure$108,000
K22 · FY2022 · AI · contact PI
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans$636,016
R01 · FY2021 · DK · contact PI
Overcoming the hurdles to successful CAR T cell therapy for a functional HIV cure$162,000
K22 · FY2021 · AI · contact PI
Interrogating mechanisms of HIV pathogenesis in the humanized BLT mouse model$71,430
F32 · FY2020 · AI · contact PI
Interrogating mechanisms of HIV pathogenesis in the humanized BLT mouse model$65,606
F32 · FY2019 · AI · contact PI
Interrogating mechanisms of HIV pathogenesis in the humanized BLT mouse model$61,174
F32 · FY2018 · AI · contact PI